revenue growth

Nvidia's $4.6T market cap limits growth potential despite 65% revenue growth; doubling more realistic than 10x returns.

Nvidia's CUDA platform with 100M+ installations creates unmatched switching costs, not just its AI chips. Stock trades at 21x forward earnings after 73% quarterly growth.

Levi Strauss posts 14% Q1 growth under turnaround strategy, raises guidance, and increases dividend 5%, with stock up 56% year-over-year.

Analyst reverses bearish stance on $PLTR citing AI boot camp model driving 109% U.S. commercial growth and 115%+ guidance, justifying 45x forward sales valuation.

K Wave Media secures global distribution rights for BTS, SEVENTEEN content. BTS world tour projected at $1.45B revenue; KWM targets $100M+ annual revenue through acquisitions and partnerships.

K Wave Media secures exclusive HYBE distribution deal for BTS, SEVENTEEN, and other artists, targeting $100M+ annual revenue by leveraging K-pop's massive 2026 touring cycle.

K Wave Media ($KWM) secures exclusive global HYBE distribution rights, targeting $100M+ annual revenue; acquisitions expected to add $50-75M more.

UPS stock falters amid labor costs and revenue decline, while mega-caps Applied Materials and Caterpillar offer superior AI infrastructure and data center opportunities.

AMD's revenue has doubled in eight quarters, narrowing Intel's lead. AMD shows 16% net income margins versus Intel's negative margins, with MI450 GPU launch potentially pushing AMD ahead by 2027.

JIADE LIMITED posts 37% revenue growth to RMB 25.70M but swings to RMB 10.53M net loss amid expansion spending. Cash surges 400% as company shifts to efficiency-focused growth.

Levi Strauss beats Q1 earnings with $1.74B revenue and raised guidance, driven by 52% DTC sales mix and 23% Beyond Yoga growth. Stock surges 11%.

RPM International stock jumps 15% after beating earnings expectations with $1.6B revenue and 57-cent EPS, driven by record margin strength.

SoundHound AI demonstrates 99% revenue growth in expanding $2.5B voice AI market projected to reach $35B by 2033, but stock declines 30% YTD as unprofitable company.

$TUTH files 2025 Annual Report; pending BRLIT acquisition targets 4x revenue growth for formerly dormant dental laboratory operator.

STAAR Surgical surges 20% after-hours on $90M Q1 sales, more than double year-ago quarter, driven by China and Americas growth despite regional headwinds.

Pure Cycle reports $5.7M net income for six months ended February 2026, with revenue up 47% YoY and rental occupancy at 95%.

$FGI raises revenue guidance to $127–$131M but slashes 2024 profit outlook to negative $1M–breakeven due to freight costs and promotions.

$LAES rises 2.83% after Q1 revenue hits $4.1M, up 200% YoY. Company reaffirms 50-100% full-year guidance despite analyst downgrade.

RPM International surges 12.44% after delivering record Q3 revenue of $1.608B and 62.9% EPS growth, with management guiding for record full-year results.

Adaptive Biotech insider sold $554K in shares via routine plan; company posted 55% revenue growth and dramatically narrowed losses, signaling operational inflection.